✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Vineet Laboratories Ltd.

VINEETLAB

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹38 Cr.
P/E
0.00

Vineet Laboratories Ltd.

  • Vineet Laboratories
  • Medistep Healthcare
  • Sandu Pharmaceutical

FAQs on Vineet Laboratories Ltd. Shareprice

Vineet Laboratories has given lower returns compared to its competitors.
Vineet Laboratories has grown at ~-14.62% over the last 4yrs while peers have grown at a median rate of -1.0%

Vineet Laboratories is not expensive.
Latest PE of Vineet Laboratories is 0.0, while 3 year average PE is 41.32.
Also latest EV/EBITDA of Vineet Laboratories is 0.0 while 3yr average is 10.86.

View FAQ's On Business

Growth Table

  • Vineet Laboratories Ltd.
  • Medistep Healthcare
  • Sandu Pharmaceutical

Balance Sheet

  • Vineet Laboratories Ltd.
  • Medistep Healthcare
  • Sandu Pharmaceutical

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Vineet Laboratories Ltd.
  • Medistep Healthcare
  • Sandu Pharmaceutical

Cash Flow

  • Vineet Laboratories Ltd.
  • Medistep Healthcare
  • Sandu Pharmaceutical

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Vineet Laboratories Ltd.
  • Medistep Healthcare
  • Sandu Pharmaceutical

Quarterly Results

  • Vineet Laboratories Ltd.
  • Medistep Healthcare
  • Sandu Pharmaceutical

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Vineet Laboratories Ltd. Financials

Vineet Laboratories balance sheet is weak and might have solvency issues

Yes, The net debt of Vineet Laboratories is increasing.
Latest net debt of Vineet Laboratories is ₹42.13 Crs as of Sep-25.
This is greater than Mar-25 when it was ₹38.8 Crs.

The profit is oscillating.
The profit of Vineet Laboratories is -₹16.7 Crs for TTM, -₹20.19 Crs for Mar 2025 and ₹1.03 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Vineet Laboratories latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech